Capital Analysts LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$104K Buy
6,203
+1,061
+21% +$17.8K ﹤0.01% 660
2025
Q1
$79K Buy
5,142
+526
+11% +$8.08K ﹤0.01% 694
2024
Q4
$102K Buy
+4,616
New +$102K ﹤0.01% 610
2024
Q2
Sell
-196
Closed -$3K 1234
2024
Q1
$3K Hold
196
﹤0.01% 1033
2023
Q4
$2K Hold
196
﹤0.01% 1036
2023
Q3
$2K Hold
196
﹤0.01% 1064
2023
Q2
$1K Hold
196
﹤0.01% 992
2023
Q1
$2K Hold
196
﹤0.01% 929
2022
Q4
$2K Hold
196
﹤0.01% 1006
2022
Q3
$2K Hold
196
﹤0.01% 1020
2022
Q2
$1K Hold
196
﹤0.01% 998
2022
Q1
$2K Hold
196
﹤0.01% 883
2021
Q4
$2K Hold
196
﹤0.01% 960
2021
Q3
$2K Hold
196
﹤0.01% 936
2021
Q2
$2K Sell
196
-103
-34% -$1.05K ﹤0.01% 893
2021
Q1
$3K Buy
+299
New +$3K ﹤0.01% 936
2017
Q3
Sell
-2,120
Closed -$70.4K 464
2017
Q2
$70.4K Hold
2,120
0.01% 277
2017
Q1
$68K Sell
2,120
-50
-2% -$1.6K 0.01% 241
2016
Q4
$79K Buy
2,170
+550
+34% +$20K 0.01% 236
2016
Q3
$74.5K Buy
1,620
+115
+8% +$5.29K 0.01% 229
2016
Q2
$75.6K Buy
1,505
+280
+23% +$14.1K 0.02% 228
2016
Q1
$65.5K Buy
1,225
+100
+9% +$5.35K 0.01% 250
2015
Q4
$73.8K Buy
1,125
+65
+6% +$4.27K 0.02% 243
2015
Q3
$59.8K Buy
1,060
+350
+49% +$19.8K 0.01% 267
2015
Q2
$42K Buy
710
+50
+8% +$2.96K 0.01% 297
2015
Q1
$41.1K Buy
660
+65
+11% +$4.05K 0.01% 301
2014
Q4
$34.2K Buy
595
+245
+70% +$14.1K 0.01% 294
2014
Q3
$18.8K Hold
350
﹤0.01% 317
2014
Q2
$18.3K Hold
350
﹤0.01% 314
2014
Q1
$18.5K Buy
350
+150
+75% +$7.93K ﹤0.01% 285
2013
Q4
$8.02K Buy
+200
New +$8.02K ﹤0.01% 298